Back to results
US 8,895,591 B2Granted
Tricyclic compound and pharmaceutical use thereof
AssigneeTakeda Pharmaceutical Company Limited
InventorsOsamu Uchikawa, Tatsuki Koike, Yasutaka Hoashi, Takafumi Takai
Life of this patent
Estimating the term…
Abstract
The present invention provides a compound represented by the formula which is useful as an agent for the prophylaxis or treatment of diseases related to the action of melatonin, or a salt thereof and the like.
Claims12
A pharmaceutical composition comprising
- (S)—N-[2-(2-methyl-7,8-dihydro-6H-indeno[5,4-d][1,3]oxazol-8-yl)ethyl]acetamide,
- (S)—N-[2-(2-methyl-7,8-dihydro-6H-indeno[5,4-d][1,3]oxazol-8-yl)ethyl]propionamide, or
- (S)—N-[2-(2-methyl-7,8-dihydro-6H-indeno[5,4-d][1,3]thiazol-8-yl)ethyl]acetamide or a pharmaceutically acceptable salt or prodrug thereof, and a pharmaceutically acceptable carrier.
A pharmaceutical composition comprising
- (S)—N-[2-(2-methyl-7,8-dihydro-6H-indeno[5,4-d][1,3]oxazol-8-yl)ethyl]acetamide or a pharmaceutically acceptable salt or prodrug thereof, and a pharmaceutically acceptable carrier.
A pharmaceutical composition comprising
- (S)—N-[2-(2-methyl-7,8-dihydro-6H-indeno[5,4-d][1,3]oxazol-8-yl)ethyl]propionamide or a pharmaceutically acceptable salt or prodrug thereof, and a pharmaceutically acceptable carrier.
A pharmaceutical composition comprising
- (S)—N-[2-(2-methyl-7,8-dihydro-6H-indeno[5,4-d][1,3]thiazol-8-yl)ethyl]acetamide or a pharmaceutically acceptable salt or prodrug thereof, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.